Ferrari Paola, Malanchini Giovanni, Limonta Raul, Ferrari Gabriele, Leidi Cristina, De Filippo Paolo
ASST Papa Giovanni XXIII Hospital, 24123 Bergamo, Italy.
School of Medicine and Surgery, University of Milan-Bicocca, 20100 Milan, Italy.
J Clin Med. 2025 Jan 21;14(3):659. doi: 10.3390/jcm14030659.
: Catheter ablation of right anterior, anterior-lateral, and anterior-septal accessory pathways is still challenging in children, even after seminal improvements in mapping and catheter design over the last years. The trans-jugular approach was described as an alternative to the femoral vein recently. As a direct comparison between the femoral approach and the superior approach using the axillary vein was lacking, we conducted the present study. Twenty-two pediatric patients were enrolled in this retrospective study. Patients with prior ablation attempts were excluded. Another 22 consecutive patients with the same AP localizations were selected as a control group and treated with ablation through the femoral vein. Left axillary vein cannulation was performed advancing an 18-gauge needle using fluoroscopic landmarks (the first rib below the inferior border of the clavicle). All mapping and ablations of accessory pathways were performed with a 7 F deflectable radiofrequency ablation catheter. The main outcome of this study was ablation success at 1 year. Recurrences were defined as a relapse of preexcitation on a 12-lead electrocardiogram and/or documented supraventricular tachycardia. There were no significant differences in sex, age, or weight between groups. No complications occurred acutely or during follow-up. There were no significant differences in acute success rates between the two groups (19/22 vs. 22/22; = 0.56) at 24 h ECG recordings. At the 1-year follow-up the total recurrence rate was 15.9% (7/44 patients); there was a significantly lower recurrence rate among patients in the trans-jugular group (27.2% vs. 4.5%; = 0.039). The present study suggests that the trans-axillary vein approach is a safe and effective alternative to the classical femoral approach in pediatric patients.
即使在过去几年中,标测和导管设计有了重大改进,但儿童右前、前外侧和前间隔旁道的导管消融仍然具有挑战性。经颈静脉途径最近被描述为股静脉途径的替代方法。由于缺乏股静脉途径与使用腋静脉的上腔静脉途径的直接比较,我们进行了本研究。22例儿科患者纳入了这项回顾性研究。排除既往有消融尝试的患者。另外选取22例连续的具有相同旁道定位的患者作为对照组,通过股静脉进行消融治疗。使用荧光透视标记(锁骨下缘下方的第一肋骨)推进18号穿刺针进行左腋静脉插管。所有旁道的标测和消融均使用7F可弯曲射频消融导管进行。本研究的主要结局是1年时消融成功。复发定义为12导联心电图上预激复发和/或记录到的室上性心动过速。两组之间在性别、年龄或体重方面无显著差异。在急性期间或随访期间均未发生并发症。在24小时心电图记录时,两组之间的急性成功率无显著差异(19/22 vs. 22/22;P = 0.56)。在1年随访时,总复发率为15.9%(44例患者中有7例);经颈静脉组患者的复发率显著更低(27.2% vs. 4.5%;P = 0.039)。本研究表明,在儿科患者中,经腋静脉途径是经典股静脉途径的一种安全有效的替代方法。